[1]王 玲,金晓雪,刘德敏,等.腔内影像技术指导下的PCI精准治疗策略研究进展[J].介入放射学杂志,2023,32(08):816-820.
　WANG Lin,JIN Xiaoxue,LIU Demin,et al.Research progress in precise treatment strategies for PCI under the guidance of intraluminal imaging technology[J].journal interventional radiology,2023,32(08):816-820.
点击复制

腔内影像技术指导下的PCI精准治疗策略研究进展()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年08
页码:
816-820
栏目:
综述
出版日期:
2023-08-29

文章信息/Info

Title:
Research progress in precise treatment strategies for PCI under the guidance of intraluminal imaging technology
作者:
王 玲;  金晓雪;  刘德敏;  崔 炜
Author(s):
WANG Lin;  JIN Xiaoxue;  LIU Demin;  CUI Wei.
Department of Cardiology， Second Hospital of Hebei Medical University， Shijiazhuang， Hebei Province 050000， China
关键词:
【关键词】 冠心病;  经皮冠状动脉介入治疗;  血管内超声;  光学相干断层成像
文献标志码:
A
摘要:
【摘要】 腔内影像学作为三维成像，较二维的冠状动脉造影更能准确地反映血管腔内结构及识别病变斑块的性质，因此有助于介入术前支架或球囊类型和置入部位的选择，指导不同类型病变合理的预处理方式，并证实可以优化左主干及慢性完全性闭塞病变介入治疗的策略，最终减少并发症及不良事件的发生。本综述从国内外循证医学证据和指南的角度，介绍了冠脉介入治疗腔内影像学研究在优化经皮冠状动脉介入治疗中的最新进展。

参考文献/References:

［1］ Raber L，Mintz GS，Koskinas KC，et al. Clinical use of intracoronary imaging. Part 1： guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions［J］. Eur Heart J， 2018， 39： 3281- 3300.
［2］ Johnson TW，Raber L，di Mario C，et al. Clinical use of intracoronary imaging. Part 2： acute coronary syndromes， ambiguous coronary angiography findings， and guiding interventional decision- making： an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions［J］. Eur Heart J， 2019， 40： 2566- 2584.
［3］ Mushenkova NV， Summerhill VI， Zhang D， et al. Current advances in the diagnostic imaging of atherosclerosis： insights into the pathophysiology of vulnerable plaque［J］. Int J Mol Sci， 2020， 21： 2992.
［4］ Kubo T， Terada K， Ino Y， et al. Combined use of multiple intravascular imaging techniques in acute coronary syndrome［J］. Front Cardiovasc Med， 2021， 8： 824128.
［5］ Shishikura D， Kataoka Y， Di Giovanni G， et al. Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events［J］. Eur Heart J， 2020， 41： 2965- 2973.
［6］ Prati F， Romagnoli E， Gatto L， et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome： the CLIMA study［J］. Eur Heart J， 2020， 41： 383- 391.
［7］ Erlinge D， Maehara A， Ben- Yehuda O， et al. Identification of vulnerable plaques and patients by intracoronary near- infrared spectroscopy and ultrasound（PROSPECT Ⅱ）： a prospective natural history study［J］. Lancet， 2021， 397： 985- 995.
［8］ Stone GW， Maehara A， Ali ZA， et al. Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque［J］. J Am Coll Cardiol， 2020， 76： 2289- 2301.
［9］ Khalifa AKM， Kubo TKH， Ino Y， et al. Optical coherence tomography comparison of percutaneous coronary intervention among plaque rupture， erosion， and calcified nodule in acute myocardial infarction［J］. Circ J， 2020， 84： 911- 916.
［10］ Fujino A， Mintz GS， Lee T， et al. Predictors of calcium fracture derived from balloon angioplasty and its effect on stent expansion assessed by optical coherence tomography［J］. JACC Cardiovasc Interv， 2018， 11： 1015- 1017.
［11］ Sugawara Y， Ueda T， Soeda T， et al. Plaque modification of severely calcified coronary lesions by scoring balloon angioplasty using lacrosse non- slip element： insights from an optical coherence tomography evaluation［J］. Cardiovasc Interv Ther， 2019， 34： 242- 248.
［12］ Riley RF， Henry TD， Mahmud E， et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease［J］. Catheter Cardiovasc Interv， 2020， 96： 346- 362.
［13］ Yerasi C， Case BC， Forrestal BJ， et al. Drug- coated balloon for de novo coronary artery disease： JACC state- of- the- art review［J］. J Am Coll Cardiol， 2020， 75： 1061- 1073.
［14］ 胡学俊，马小林，刘 冰，等． 药物涂层球囊治疗新生冠状动脉病变45例临床分析［J］． 介入放射学杂志， 2020， 29：1258- 1261．
［15］ Jung HW， Lim C， Bae HJ， et al. Association between in- stent neointimal characteristics and native coronary artery disease progression［J］. PLoS One， 2021， 16： e0247359.
［16］ Almeda FQ， Klein LW. Cutting balloon angioplasty： to cut is to cure?［J］. J Invasive Cardiol， 2002， 14： 725- 727.
［17］ Ali ZA， Maehara A， Genereux P， et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation （ILUMIEN Ⅲ： OPTIMIZE PCI）： a randomised controlled trial［J］. Lancet， 2016， 388： 2618- 2628.
［18］ Neumann FJ， Sousa- Uva M， Ahlsson A， et al. 2018 ESC/EACTS guidelines on myocardial revascularization［J］. Eur Heart J， 2019， 40： 87- 165.
［19］ 张 蛟，段媛媛，魏玉杰，等． 支架影像增强显影指导冠状动脉开口病变介入治疗临床应用［J］． 介入放射学杂志， 2015， 24：662- 667．
［20］ Park SJ， Ahn JM， Kang SJ， et al. Intravascular ultrasound- derived minimal lumen area criteria for functionally significant left main coronary artery stenosis［J］. JACC Cardiovasc Interv， 2014， 7： 868- 874.
［21］ Kang SJ， Ahn JM， Song H， et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease［J］. Circ Cardiovasc Interv， 2011， 4： 562- 569.
［22］ Lassen JF，Burzotta F，Banning AP，et al. Percutaneous coronary intervention for the left main stem and other bifurcation lesions： 12th consensus document from the European Bifurcation Club［J］. EuroIntervention， 2018， 13： 1540- 1553.
［23］ Cortese B， Burzotta F， Alfonso F， et al. Role of optical coherence tomography for distal left main stem angioplasty［J］. Catheter Cardiovasc Interv， 2020， 96： 755- 761.
［24］ 沈卫峰，丁风华，张瑞岩． 冠状动脉腔内影像学指导左主干病变介入治疗［J］． 中国介入心脏病学杂志， 2021， 29：481- 483．
［25］ Amabile N， Range G， Souteyrand G， et al. Optical coherence tomography to guide percutaneous coronary intervention of the left main coronary artery： the LEMON study［J］. EuroIntervention， 2021， 17： e124- e131.
［26］ Kinnaird T，Johnson T，Anderson R，et al. Intravascular imaging and 12- month mortality after unprotected left main stem PCI： an analysis from the British cardiovascular intervention society database［J］. JACC Cardiovasc Interv， 2020， 13： 346- 357.
［27］ Darmoch F， Alraies MC， Al- Khadra Y， et al. Intravascular ultrasound imaging- guided versus coronary angiography- guided percutaneous coronary intervention： a systematic review and meta- analysis［J］. J Am Heart Assoc， 2020， 9： e013678.
［28］ Kalogeropoulos AS， Alsanjari O， Davies JR， et al. Impact of intravascular ultrasound on chronic total occlusion percutaneous revascularization［J］. Cardiovasc Revasc Med， 2021， 33： 32- 40.
［29］ de la Torre Hernandez JM. Intravascular ultrasound in percutaneous coronary intervention for in- stent chronic total occlusion： guidance for long- term success［J］. EuroIntervention， 2020， 16： e445- e447.
［30］ Prasad M， Maehara A， Ahmad Y， et al. Intravascular ultrasound in chronic total occlusion percutaneous coronary intervention： solving ambiguity and improving durability［J］. Interv Cardiol Clin， 2021， 10： 75- 85.
［31］ Sanidas EA. IVUS in CTO lesions：“Rolling Into Deep”［J］. JACC Case Rep， 2020， 2： 966- 967.
［32］ Hong SJ， Kim BK， Kim YJ， et al. Incidence， predictors， and outcomes of distal vessel expansion on follow- up intravascular ultrasound after recanalization of chronic total occlusions using new- generation drug- eluting stents： data from the CTO- IVUS randomized trial［J］. Catheter Cardiovasc Interv， 2020， 95： 154- 164.
［33］ Shlofmitz E， Torguson R， Zhang C， et al. Impact of intravascular ultrasound on outcomes following percutaneous coronary intervention in complex lesions（iOPEN complex）［J］. Am Heart J， 2020， 221： 74- 83.
［34］ Mashayekhi K， Behnes M. The role of intravascular ultrasound in the treatment of chronic total occlusion with percutaneous coronary intervention［J］. Cardiol J， 2020， 27： 4- 5.
［35］ Vemmou E， Khatri J， Doing AH， et al. Impact of intravascular ultrasound utilization for stent optimization on 1- year outcomes after chronic total occlusion percutaneous coronary intervention［J］. J Invasive Cardiol， 2020， 32： 392- 399.
［36］ Yoon YH， Lee PH， Lee SW， et al. Clinical outcomes after percutaneous coronary intervention for in- stent chronic total occlusion［J］. EuroIntervention， 2020， 16： e472- e479.
［37］ 杨跃进，宋 雷，李向东，等． 血管内超声指导前向主动真腔寻径（IVUS- ATS）：一种开通复杂冠状动脉慢性完全闭塞病变的创新技术［J］． 中国循环杂志， 2019， 34：417- 421．
［38］ 宋 雷，张 晗，杨跃进． 血管内超声在慢性完全闭塞病变介入治疗中的价值［J］． 中国介入心脏病学杂志， 2021， 29：515- 519．

相似文献/References:

[1]戴 煌,秦永文,萧 毅.320排动态容积CT冠状动脉成像诊断冠心病的初步应用[J].介入放射学杂志,2012,(07):541.
　DAI Huang,QIN Yong- wen,XIAO Yi.. Preliminary application of 320-detector row dynamic volume CT angiography in diagnosing coronary heart diseases[J].journal interventional radiology,2012,(08):541.
[2]罗育坤,范 林,林朝贵,等. 破裂斑块行介入治疗对冠状动脉血流的影响[J].介入放射学杂志,2012,(11):898.
　LUO Yu-kun,FAN Lin,LIN Chao- gui,et al. Changes of coronary flow occurred after percutaneous coronary intervention for ruptured plaque detected by intravascular ultrasound[J].journal interventional radiology,2012,(08):898.
[3]徐翠荣,李国宏,陈 泳,等. 临床路径在急性心肌梗死介入治疗整体护理中的应用[J].介入放射学杂志,2012,(12):1046.
　XU Cui? rong,LI Guo? hong,CHEN Yong,et al. The application of clinical nursing path in holistic nursing care for patients with acute myocardial infarction treated with emergency percutaneous coronary intervention[J].journal interventional radiology,2012,(08):1046.
[4]潘静薇,陆志刚,张佳胤,等. 冠状动脉介入治疗后迟发型对比剂肾病[J].介入放射学杂志,2013,(01):15.
　PAN Jing? wei,LU Zhi? gang,ZHANG Jia? yin,et al. Delayed contrast?蛳 induced nephropathy occurring after percutaneous coronary intervention[J].journal interventional radiology,2013,(08):15.
[5]彭育红,汝磊生,王冬梅,等.国产无聚合物紫杉醇微孔载药支架与雷帕霉素涂层支架对比治疗急性心肌梗死[J].介入放射学杂志,2013,(06):458.
　PENG Yu? hong,RU Lei? sheng,WANG Dong? mei,et al. Domestic polymer- free paclitaxel- eluting stent and polymer-based rapamycin- eluting stent for the treatment of acute myocardial infarction： a comparison study[J].journal interventional radiology,2013,(08):458.
[6]王智廷,曹国全,闻彩云,等. 冠状动脉介入治疗中操作者所受剂量的综合研究[J].介入放射学杂志,2013,(10):834.
　WANG Zhi? ting,CAO Guo? quan,WEN Cai? yun. HUANG Zhou? qing.. The radiation dose to operators in performing percutaneous coronary intervention： a comprehensive study[J].journal interventional radiology,2013,(08):834.
[7]孙俊翔,陈燕春,殷云杰,等.脂蛋白（a）与稳定型心绞痛患者经皮冠状动脉介入治疗围术期心肌损伤研究[J].介入放射学杂志,2019,28(01):19.
　SUN Junxiang,CHEN Yanchun,YIN Yunjie,et al.The correlation between lipoprotein level and perioperative myocardial injury in patients with stable angina after percutaneous coronary intervention[J].journal interventional radiology,2019,28(08):19.
[8]李文庆,程志勇,魏明霞,等.血管内超声指导介入治疗冠状动脉分叉病变临床研究[J].介入放射学杂志,2015,(04):292.
　LI Wen qing,CHENG Zhi yong,WEI Ming xia,et al.Intravascular ultrasound guided interventional treatment of coronary true bifurcation lesions： a clinical study[J].journal interventional radiology,2015,(08):292.
[9]潘春仰,邱建平,陆 林,等.冠状动脉介入治疗后支架内再狭窄相关因素[J].介入放射学杂志,2015,(06):467.
　PAN Chun-yang,QIU Jian-ping,LU Lin,et al.Investigation of factors related to the occurrence of in-stent restenosis after percutaneous coronary intervention[J].journal interventional radiology,2015,(08):467.
[10]刘伟宾,黄连军,郭久芳,等.冠心病介入诊疗中透视与电影辐射剂量率对比分析[J].介入放射学杂志,2015,(06):524.
　LIU Wei-bin,HUANG Lian-jun,GUO Jiu-fang,et al.Radiation dose rate received by patients with coronary heart disease during interventional management： comparison between fluoroscopy and movies[J].journal interventional radiology,2015,(08):524.
[11]胡中耀,赵文艺,丁守坤.冠状动脉性心脏病患者经皮冠状动脉介入治疗后脑源性神经营养因子和肾胺酶水平变化及意义[J].介入放射学杂志,2020,29(07):698.
　HU Zhongyao,ZHAO Wenyi,Changes of brain-derived neurotrophic factor and renalase levels in patients with coronary heart disease after percutaneous coronary intervention and their clinical significance[J].journal interventional radiology,2020,29(08):698.

备注/Memo

备注/Memo:
（收稿日期：2022- 06- 06）
（本文编辑：茹 实）
更新日期/Last Update: 2023-08-29